Reduced nicotinamide mononucleotide is a new and potent NAD + precursor in mammalian cells and mice-Reference-Cited by-同舟云学术

Reduced nicotinamide mononucleotide is a new and potent NAD + precursor in mammalian cells and mice

Published:2021-03-16 Issue:4 Volume:35 Page:
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Zapata‐Pérez Rubén¹^ORCID,Tammaro Alessandra²^ORCID,Schomakers Bauke V.¹³,Scantlebery Angelique M. L.¹,Denis Simone¹,Elfrink Hyung L.¹³,Giroud‐Gerbetant Judith⁴,Cantó Carles⁴,López‐Leonardo Carmen⁵,McIntyre Rebecca L.¹,van Weeghel Michel¹³,Sánchez‐Ferrer Álvaro⁶,Houtkooper Riekelt H.¹^ORCID

Affiliation:

1. Laboratory Genetic Metabolic Diseases Amsterdam Gastroenterology, Endocrinology, and Metabolism Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam Amsterdam The Netherlands

2. Pathology Department Amsterdam UMC, University of Amsterdam Amsterdam The Netherlands

3. Core Facility Metabolomics Amsterdam UMC, University of Amsterdam Amsterdam the Netherlands

4. Nestlé Institute of Health Sciences Nestlé Research Lausanne Switzerland

5. Department of Organic Chemistry University of Murcia Murcia Spain

6. Department of Biochemistry and Molecular Biology‐A University of Murcia Murcia Spain

Funder

Horizon 2020

European Research Council

ZonMw

Velux Stiftung

Ministerio de Economía y Competitividad

Publisher